National Academies Press: OpenBook
Suggested Citation:"Front Matter." Institute of Medicine. 2014. Discussion Framework for Clinical Trial Data Sharing: Guiding Principles, Elements, and Activities. Washington, DC: The National Academies Press. doi: 10.17226/18610.
×

DISCUSSION FRAMEWORK FOR
CLINICAL TRIAL DATA SHARING

GUIDING PRINCIPLES, ELEMENTS, AND ACTIVITIES

Committee on Strategies for Responsible
Sharing of Clinical Trial Data

Board on Health Sciences Policy

INSTITUTE OF MEDICINE
       OF THE NATIONAL ACADEMIES

THE NATIONAL ACADEMIES PRESS

Washington, D.C.

www.nap.edu

Suggested Citation:"Front Matter." Institute of Medicine. 2014. Discussion Framework for Clinical Trial Data Sharing: Guiding Principles, Elements, and Activities. Washington, DC: The National Academies Press. doi: 10.17226/18610.
×

THE NATIONAL ACADEMIES PRESS • 500 Fifth Street, NW • Washington, DC 20001

NOTICE: The project that is the subject of this report was approved by the Governing Board of the National Research Council, whose members are drawn from the councils of the National Academy of Sciences, the National Academy of Engineering, and the Institute of Medicine. The members of the committee responsible for the report were chosen for their special competences and with regard for appropriate balance.

This study was supported by contracts between the National Academy of Sciences and the U.S. National Institutes of Health (HHSN263201200074I), U.S. Food and Drug Administration, AbbVie Inc., Amgen Inc., AstraZeneca Pharmaceuticals, Bayer, Biogen Idec, Bristol-Myers Squibb, Burroughs Wellcome Fund, Doris Duke Charitable Foundation, Eli Lilly and Company, EMD Serono, Genentech, GlaxoSmithKline, Johnson & Johnson, Medical Research Council (UK), Merck & Co., Inc., Novartis Pharmaceuticals Corporation, Novo Nordisk, Pfizer Inc., Sanofi-Aventis, Takeda, and Wellcome Trust. Any opinions, findings, conclusions, or recommendations expressed in this publication are those of the author(s) and do not necessarily reflect the views of the organizations or agencies that provided support for the project.

Additional copies of this report are available for sale from the National Academies Press, 500 Fifth Street, NW, Keck 360, Washington, DC 20001; (800) 624-6242 or (202) 334-3313; http://www.nap.edu.

For more information about the Institute of Medicine, visit the IOM home page at: www.iom.edu.

Copyright 2014 by the National Academy of Sciences. All rights reserved.

Printed in the United States of America

The serpent has been a symbol of long life, healing, and knowledge among almost all cultures and religions since the beginning of recorded history. The serpent adopted as a logotype by the Institute of Medicine is a relief carving from ancient Greece, now held by the Staatliche Museum in Berlin.

Suggested citation: IOM (Institute of Medicine). 2014. Discussion framework for clinical trial data sharing: Guiding principles, elements, and activities. Washington, DC: The National Academies Press.

Suggested Citation:"Front Matter." Institute of Medicine. 2014. Discussion Framework for Clinical Trial Data Sharing: Guiding Principles, Elements, and Activities. Washington, DC: The National Academies Press. doi: 10.17226/18610.
×

Knowing is not enough; we must apply.
Willing is not enough; we must do.
”      

                                                —Goethe

image

INSTITUTE OF MEDICINE
              OF THE NATIONAL ACADEMIES

Advising the Nation. Improving Health.

Suggested Citation:"Front Matter." Institute of Medicine. 2014. Discussion Framework for Clinical Trial Data Sharing: Guiding Principles, Elements, and Activities. Washington, DC: The National Academies Press. doi: 10.17226/18610.
×

THE NATIONAL ACADEMIES

Advisers to the Nation on Science, Engineering, and Medicine

The National Academy of Sciences is a private, nonprofit, self-perpetuating society of distinguished scholars engaged in scientific and engineering research, dedicated to the furtherance of science and technology and to their use for the general welfare. Upon the authority of the charter granted to it by the Congress in 1863, the Academy has a mandate that requires it to advise the federal government on scientific and technical matters. Dr. Ralph J. Cicerone is president of the National Academy of Sciences.

The National Academy of Engineering was established in 1964, under the charter of the National Academy of Sciences, as a parallel organization of outstanding engineers. It is autonomous in its administration and in the selection of its members, sharing with the National Academy of Sciences the responsibility for advising the federal government. The National Academy of Engineering also sponsors engineering programs aimed at meeting national needs, encourages education and research, and recognizes the superior achievements of engineers. Dr. C. D. Mote, Jr., is president of the National Academy of Engineering.

The Institute of Medicine was established in 1970 by the National Academy of Sciences to secure the services of eminent members of appropriate professions in the examination of policy matters pertaining to the health of the public. The Institute acts under the responsibility given to the National Academy of Sciences by its congressional charter to be an adviser to the federal government and, upon its own initiative, to identify issues of medical care, research, and education. Dr. Harvey V. Fineberg is president of the Institute of Medicine.

The National Research Council was organized by the National Academy of Sciences in 1916 to associate the broad community of science and technology with the Academy’s purposes of furthering knowledge and advising the federal government. Functioning in accordance with general policies determined by the Academy, the Council has become the principal operating agency of both the National Academy of Sciences and the National Academy of Engineering in providing services to the government, the public, and the scientific and engineering communities. The Council is administered jointly by both Academies and the Institute of Medicine. Dr. Ralph J. Cicerone and Dr. C. D. Mote, Jr., are chair and vice chair, respectively, of the National Research Council.

www.national-academies.org

Suggested Citation:"Front Matter." Institute of Medicine. 2014. Discussion Framework for Clinical Trial Data Sharing: Guiding Principles, Elements, and Activities. Washington, DC: The National Academies Press. doi: 10.17226/18610.
×

COMMITTEE ON STRATEGIES FOR RESPONSIBLE SHARING OF CLINICAL TRIAL DATA

BERNARD LO (Chair), President, The Greenwall Foundation, New York City, New York

TIMOTHY COETZEE, Chief Advocacy, Services, and Research Officer, National Multiple Sclerosis Society

DAVE DEMETS, Professor and Chair, Department of Biostatistics and Medical Informatics, University of Wisconsin, Madison

JEFFREY DRAZEN, Editor-in-Chief, New England Journal of Medicine

STEVEN GOODMAN, Professor, Medicine & Health Research & Policy, Stanford University School of Medicine

PATRICIA KING, Carmack Waterhouse Professor of Law, Medicine, Ethics, and Public Policy, Georgetown University Law Center

TRUDIE LANG, Principal Investigator, Global Health Network, Nuffield Department of Medicine, University of Oxford

DEVEN MCGRAW, Director, Health Privacy Project, Center for Democracy & Technology

ELIZABETH NABEL, President, Brigham and Women’s Hospital

ARTI RAI, Elvin R. Latty Professor of Law, Duke University School of Law

IDA SIM, Professor of Medicine and Co-Director of Biomedical Informatics of the Clinical and Translational Science Institute, University of California at San Francisco

SHARON TERRY, President and CEO, Genetic Alliance

JOANNE WALDSTREICHER, Chief Medical Officer, Johnson & Johnson

IOM Staff

ANNE B. CLAIBORNE, Senior Program Officer

LEIGHANNE OLSEN, Interim Study Director (until November 2013)

REBECCA N. LENZI, Study Director (from November 2013)

MICHELLE MANCHER, Associate Program Officer

RACHEL KIRKLAND, Senior Program Assistant (until October 2013)

BARRET J. ZIMMERMANN, Senior Program Assistant (from October 2013)

ANDREW M. POPE, Director, Board on Health Sciences Policy

Consultant

THERESA WIZEMANN, Wizemann Scientific Communications, LLC

Suggested Citation:"Front Matter." Institute of Medicine. 2014. Discussion Framework for Clinical Trial Data Sharing: Guiding Principles, Elements, and Activities. Washington, DC: The National Academies Press. doi: 10.17226/18610.
×

This page intentionally left blank.

Suggested Citation:"Front Matter." Institute of Medicine. 2014. Discussion Framework for Clinical Trial Data Sharing: Guiding Principles, Elements, and Activities. Washington, DC: The National Academies Press. doi: 10.17226/18610.
×

Reviewers

This report has been reviewed in draft form by individuals chosen for their diverse perspectives and technical expertise, in accordance with procedures approved by the National Research Council’s Report Review Committee. The purpose of this independent review is to provide candid and critical comments that will assist the institution in making its published report as sound as possible and to ensure that the report meets institutional standards for objectivity, evidence, and responsiveness to the study charge. The review comments and draft manuscript remain confidential to protect the integrity of the deliberative process. We wish to thank the following individuals for their review of this report:

Lawrence J. Appel, Johns Hopkins Medical Institutions

Marc Boutin, National Health Council

Kay Dickersin, Johns Hopkins Bloomberg School of Public Health

David Harrington, Harvard School of Public Health

Peter S. Kim, Stanford University School of Medicine

Bartha Knoppers, McGill University

David Korn, Harvard University

Harlan M. Krumholz, Yale University School of Medicine

Christine Laine, Annals of Internal Medicine

Sir Michael Rawlins, Royal Society of Medicine

Jerome P. Reiter, Duke University

Donald M. Steinwachs, Johns Hopkins University

Alan M. Zaslavsky, Harvard Medical School

Page viii Cite
Suggested Citation:"Front Matter." Institute of Medicine. 2014. Discussion Framework for Clinical Trial Data Sharing: Guiding Principles, Elements, and Activities. Washington, DC: The National Academies Press. doi: 10.17226/18610.
×

Although the reviewers listed above have provided many constructive comments and suggestions, they were not asked to endorse the conclusions or recommendations, nor did they see the final draft of the report before its release. The review of this report was overseen by Enriqueta C. Bond, QE Philanthropic Advisors, and Stephen E. Fienberg, Carnegie Mellon University. Appointed by the Institute of Medicine and the National Research Council, they were responsible for making certain that an independent examination of this report was carried out in accordance with institutional procedures and that all review comments were carefully considered. Responsibility for the final content of this report rests entirely with the authoring committee and the institution.

Suggested Citation:"Front Matter." Institute of Medicine. 2014. Discussion Framework for Clinical Trial Data Sharing: Guiding Principles, Elements, and Activities. Washington, DC: The National Academies Press. doi: 10.17226/18610.
×

Preface

Sharing data generated through the conduct of clinical trials offers the promise of placing evidence about the safety and efficacy of therapies and clinical interventions on a firmer basis and enhancing the benefits of clinical trials. Ultimately, such data sharing—if carried out appropriately—could lead to improved clinical care and greater public trust in clinical research and health care. However, recommending strategies for how clinical trial data could be shared responsibly is a difficult process—many stakeholders have valid interests that sometimes are not aligned; different models and approaches have been proposed or tried; and proposing an approach that works for the wide range of clinical trials may be daunting. Undergirding any discussion of possibilities and needs for clinical trial data sharing is a fundamental philosophical question: To whom ought the benefits of the data belong, and, accordingly, where lies the presumption as to whether data ought to be shared?

The Institute of Medicine (IOM) has assembled a committee with interdisciplinary expertise and a wide range of backgrounds to study how data from clinical trials might best be shared. The fulfillment of the committee’s task requires careful gathering of evidence and listening to and understanding different viewpoints. We plan to learn from what has already been proposed and tried.

As the committee is charged in its statement of task, this document is designed as a framework for discussion. This framework is being released to stimulate reactions and comments from stakeholders and the public. In addition to seeking comments generally, we also have posed several specific questions for which feedback and suggestions would be particularly useful as we move our deliberations forward. Although we welcome comments at any time throughout the study process, comments

Suggested Citation:"Front Matter." Institute of Medicine. 2014. Discussion Framework for Clinical Trial Data Sharing: Guiding Principles, Elements, and Activities. Washington, DC: The National Academies Press. doi: 10.17226/18610.
×

on the issues raised in this framework document would be most helpful if received by March 24, 2014. At this early stage in our work, we have reached no conclusions. As all IOM committees are called to do, we approach our charge with minds open to sound evidence and convincing arguments, and we look forward to hearing them.

This document would not have been possible without the dedicated and skilled work of IOM staff, including Anne B. Claiborne, LeighAnne Olsen, Rebecca N. Lenzi, Michelle Mancher, Rachel Kirkland, Barret J. Zimmermann, and Andrew M. Pope, whom the committee gratefully acknowledges and thanks.

Bernard Lo, Chair

Committee on Strategies for Responsible

   Sharing of Clinical Trial Data

Page xiii Cite
Suggested Citation:"Front Matter." Institute of Medicine. 2014. Discussion Framework for Clinical Trial Data Sharing: Guiding Principles, Elements, and Activities. Washington, DC: The National Academies Press. doi: 10.17226/18610.
×
Suggested Citation:"Front Matter." Institute of Medicine. 2014. Discussion Framework for Clinical Trial Data Sharing: Guiding Principles, Elements, and Activities. Washington, DC: The National Academies Press. doi: 10.17226/18610.
×

This page intentionally left blank.

Suggested Citation:"Front Matter." Institute of Medicine. 2014. Discussion Framework for Clinical Trial Data Sharing: Guiding Principles, Elements, and Activities. Washington, DC: The National Academies Press. doi: 10.17226/18610.
×
Page R1
Suggested Citation:"Front Matter." Institute of Medicine. 2014. Discussion Framework for Clinical Trial Data Sharing: Guiding Principles, Elements, and Activities. Washington, DC: The National Academies Press. doi: 10.17226/18610.
×
Page R2
Suggested Citation:"Front Matter." Institute of Medicine. 2014. Discussion Framework for Clinical Trial Data Sharing: Guiding Principles, Elements, and Activities. Washington, DC: The National Academies Press. doi: 10.17226/18610.
×
Page R3
Suggested Citation:"Front Matter." Institute of Medicine. 2014. Discussion Framework for Clinical Trial Data Sharing: Guiding Principles, Elements, and Activities. Washington, DC: The National Academies Press. doi: 10.17226/18610.
×
Page R4
Suggested Citation:"Front Matter." Institute of Medicine. 2014. Discussion Framework for Clinical Trial Data Sharing: Guiding Principles, Elements, and Activities. Washington, DC: The National Academies Press. doi: 10.17226/18610.
×
Page R5
Suggested Citation:"Front Matter." Institute of Medicine. 2014. Discussion Framework for Clinical Trial Data Sharing: Guiding Principles, Elements, and Activities. Washington, DC: The National Academies Press. doi: 10.17226/18610.
×
Page R6
Suggested Citation:"Front Matter." Institute of Medicine. 2014. Discussion Framework for Clinical Trial Data Sharing: Guiding Principles, Elements, and Activities. Washington, DC: The National Academies Press. doi: 10.17226/18610.
×
Page R7
Page viii Cite
Suggested Citation:"Front Matter." Institute of Medicine. 2014. Discussion Framework for Clinical Trial Data Sharing: Guiding Principles, Elements, and Activities. Washington, DC: The National Academies Press. doi: 10.17226/18610.
×
Page R8
Suggested Citation:"Front Matter." Institute of Medicine. 2014. Discussion Framework for Clinical Trial Data Sharing: Guiding Principles, Elements, and Activities. Washington, DC: The National Academies Press. doi: 10.17226/18610.
×
Page R9
Suggested Citation:"Front Matter." Institute of Medicine. 2014. Discussion Framework for Clinical Trial Data Sharing: Guiding Principles, Elements, and Activities. Washington, DC: The National Academies Press. doi: 10.17226/18610.
×
Page R10
Suggested Citation:"Front Matter." Institute of Medicine. 2014. Discussion Framework for Clinical Trial Data Sharing: Guiding Principles, Elements, and Activities. Washington, DC: The National Academies Press. doi: 10.17226/18610.
×
Page R11
Suggested Citation:"Front Matter." Institute of Medicine. 2014. Discussion Framework for Clinical Trial Data Sharing: Guiding Principles, Elements, and Activities. Washington, DC: The National Academies Press. doi: 10.17226/18610.
×
Page R12
Page xiii Cite
Suggested Citation:"Front Matter." Institute of Medicine. 2014. Discussion Framework for Clinical Trial Data Sharing: Guiding Principles, Elements, and Activities. Washington, DC: The National Academies Press. doi: 10.17226/18610.
×
Page R13
Suggested Citation:"Front Matter." Institute of Medicine. 2014. Discussion Framework for Clinical Trial Data Sharing: Guiding Principles, Elements, and Activities. Washington, DC: The National Academies Press. doi: 10.17226/18610.
×
Page R14
Next: Discussion Framework for Clinical Trial Data Sharing »
Discussion Framework for Clinical Trial Data Sharing: Guiding Principles, Elements, and Activities Get This Book
×
Buy Paperback | $39.00 Buy Ebook | $31.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

Sharing data generated through the conduct of clinical trials offers the promise of placing evidence about the safety and efficacy of therapies and clinical interventions on a firmer basis and enhancing the benefits of clinical trials. Ultimately, such data sharing - if carried out appropriately - could lead to improved clinical care and greater public trust in clinical research and health care.

Discussion Framework for Clinical Trial Data Sharing: Guiding Principles, Elements, and Activities is part of a study of how data from clinical trials might best be shared. This document is designed as a framework for discussion and public comment. This framework is being released to stimulate reactions and comments from stakeholders and the public. The framework summarizes the committee's initial thoughts on guiding principles that underpin responsible sharing of clinical trial data, defines key elements of clinical trial data and data sharing, and describes a selected set of clinical trial data sharing activities.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!